The PINC AI™ Applied Sciences division is leading the way with the most comprehensive database of COVID-19-related data to help understand COVID-19's clinical progression and its impact on patient care.
We’re recruiting sites and identifying patients for COVID-19 clinical trials to evaluate treatments or vaccines.
We’re bringing together influential stakeholders to gather insights, foster peer-to-peer knowledge sharing and identify best practices.
We’re conducting prospective and retrospective research such as cohort studies and comparative effectiveness studies to source and scale best practices related to COVID-19 management.
An Inflection Point for Real-world Evidence
Technology advancements in AI and machine learning helped identify patients earlier, which helped predict COVID-19’s clinical progression and overall impact on patient care. That example, as well as how to conduct evidence-based analyses in the current COVID-19 landscape, are discussed in this webinar.
COVID-19 Data Special Release
Download this white paper for a detailed description of the attributes and capabilities of PINC AI™ Healthcare Data in this special release on COVID-19.
Eight Ways the PINC AI™ Healthcare Database Has Fueled Leading COVID-19 Research
Meet our experts and put our best-in-class, HIPAA-compliant database to work for you.
As your leading research and analytics partner, PINC AI™ Applied Sciences can help your organization improve the overall quality, safety and cost-effectiveness of care.